Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANNES amantadine neuroenhancement study in acute ICU/IMC patients
2022-002418-18Phase 2Active
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amantadine in disorder of consciousness (DOC) and vegetative state (VS), sponsored by University Hospital Tübingen. Primary endpoint: Level of vigilance by Glasgow Coma Scale. Started Aug 2022; status: active.
02
Drugs
amantadine
03
Conditions
disorder of consciousness (DOC)vegetative state (VS)
Beyond the preview
Go deeper on 2022-002418-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002418-18.